New material codes for an implantable sensor for continuous measurement of glucose in interstitial fluid and embolization equipment were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in October 2019.
New material codes and related conditions of reimbursement have been implemented for the following devices:
Implantable sensor for continuous measurement of glucose in interstitial fluid:
- Devices will be reimbursed through a Limited Clinical Application (temporary reimbursement for 400 patients from 2019 to 2024). At the end of this period, the device will be evaluated
- The following material codes have been applied:
- 174370 - 174381 “First implantable sensor for continuous measurement of glucose in interstitial fluid, including accessories” with the tariff of €1,003;
- 174392 - 174403 “Implantable replacement sensor for continuous measurement of glucose in interstitial fluid, including accessories” with the tariff of €1,003;
- 174414 – 174425 “Replacement implantable sensor for continuous measurement of glucose in the interstitial fluid, including accessories, in case of early replacement” with the tariff of €1;
- 174436 – 174440 “First transmitter for an implantable sensor for continuous measurement of glucose in interstitial fluid” with the tariff of €600;
- 174451 – 174462 “Implantable sensor replacement transmitter for continuous measurement of glucose in the interstitial fluid” with the tariff of €600;
- 174473 – 174484 “Replacement transmitter for the continuous measurement of the glucose level in the interstitial fluid, in case of early replacement” with the tariff of €1;
- 174495 – 174506 “First implantable sensor for continuous measurement of glucose in the interstitial fluid, including accessories, after exceeding the total number of 400 174370-174381” with the tariff of €1,003;
- 174510 – 174521 “First transmitter for an implantable sensor for continuous measurement of glucose in the interstitial fluid, after exceeding the total number of 400 174370-174381” with the tariff of €600.
- There are specific conditions of reimbursement for these technologies, provided in paragraph M-§01 of the List of reimbursable implants and medical devices.
Embolization equipment
- Devices will be reimbursed with a generic tariff, without registration on the nominative list.
- The following material codes have been applied:
- 174016 - 174020 “Set of basic catheterization equipment for embolization in the encephalic or medullary area, by puncture site, for a percutaneous approach” with the tariff of €281;
- 174031 - 174042 “Set of basic catheterization equipment for embolization in the encephalic or medullary region with a triaxial configuration and with a "distal access" intermediate catheter, per puncture site, for a percutaneous approach” with the tariff of €954;
- 174053 - 174064 “First microcatheter and accessories for embolization in the brain or spinal region” with the tariff of €1,279;
- 174090 - 174101 “First microcatheter and accessories used during embolization with solidifying material, in the encephalic or medullary region” with the tariff of €1,365;
- 174112 - 174123 “Microcatheter and accessories used during embolization with solidifying material, in the encephalic or medullary region, by additional microcatheter” with the tariff of €1,080;
- 174134 - 174145 “Remodeling balloon with a simple light, used during embolization in the encephalic or medullary region, per piece” with the tariff of €1,276;
- 174156 - 174160 “Double-luminescent remodeling balloon, used during embolization in the encephalic or medullary region, per piece” with the tariff of €1,806;
- 174171 - 174182 “Spire detachable for embolization in the encephalic or medullary region, per piece” with the tariff of €1,180;
- 174296 – 174300 “One or more retriever thrombi for the evacuation of an intracranial thrombus that appeared during embolization in the encephalic or medullary region” with the tariff of €4,457;
- 174311 – 174322 “All dilatation and stent material used during endovascular treatment of proximal arterial constriction, to provide access to a lesion to be embolized in the encephalic or medullary area” with the tariff of €891;
- 174075 – 174086 “Microcatheter and accessories for embolization in the encephalic or medullary region, from the second microcatheter” with the tariff of €932.
- There are specific conditions of reimbursement for these technologies, provided in paragraph G-§05 of the List of reimbursable implants and medical devices.
Embolization equipment
- Devices will be reimbursed with a generic tariff but reimbursed when registered on the nominative list.
The following material codes have been applied:
- 174193 – 174204 “Stent for the support of embolization material at the neck of the aneurysm in the encephalic or medullary region, per piece” with the tariff of €4,000;
- 174215 – 174226 “Stent for the support of embolization material at the level of the neck of the aneurysm located on a bifurcation in the encephalic or medullary region, per piece” with the tariff of €9,000;
- 174230 – 174241 “Flow diversion system or intra-arterial or intravascular flow diversifier (flow diverter or flow disruptor) for remodeling arterial blood flow at the level of the aneurysm in the encephalic or medullary region, per piece” with the tariff of €13,900;
- 174252 – 174263 “Non-adhesive solidifying material and accessories for embolizing an arteriovenous fistula, malformation or tumor in the encephalic or medullary region, by kit” with the tariff of €850;
- 174274 – 174285 “Microparticles or particles of polyvinyl alcohol to embolize an arteriovenous fistula, malformation or tumor in the encephalic or medullary region, by kit” with the tariff of €155;
- There are specific conditions of reimbursement for these technologies, provided in paragraph G-§05 of the List of reimbursable implants and medical devices.
See the updated version of the List of the reimbursable devices in French and Dutch here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.